New measure of sexual arousal found for both men and women

Feb 23, 2007

According to a new study published in the latest issue of The Journal of Sexual Medicine and conducted in the Department of Psychology of McGill University, thermography shows great promise as a diagnostic method of measuring sexual arousal. It is less intrusive than currently utilized methods, and is the only available test that requires no physical contact with participants.

Thermography is currently the only method that can be used to diagnose sexual health problems in both women and men. In fact, women and men demonstrated similar patterns of temperature change during sexual arousal with no significant differences between genders in the time needed to reach peak temperature.

"Using thermography, we also found that women's subjective experience of sexual arousal corresponded with their physiological genital response; this challenges the common notion that women don't know their bodies," says Tuuli Kukkonen, a Ph.D. candidate in psychology at McGill University and lead author of the study.

"I predict that the major physiological measure of sexual arousal for most future clinical trials of female sexual arousal disorder will be genital temperature as measured by thermography," according to Dr. Yitzchak Binik, senior author of the research and Professor of Psychology at McGill and Director of the Sex and Couple Therapy Service of the McGill University Health Center (www.sexandcoupletherapy.com).

"This is a huge breakthrough in the assessment of genital blood flow research in women's sexual health," observed Irwin Goldstein, Editor-in-Chief of The Journal of Sexual Medicine. "Previous testing was invasive and involved placement of measuring instruments in various locations in the genital region and this interfered with the arousal itself. Thermography does not have any such requirements and is very user-friendly. This may be the first test to diagnose blood vessel blockage as a cause of sexual dysfunction in women, and may help identify those patients who may be helped by vasoactive drugs similar to those prescribed for men with erectile dysfunction from narrowed blood vessels."

Source: Blackwell Publishing

Explore further: Decisions to forgo life support may depend heavily on the ICU where patients are treated

add to favorites email to friend print save as pdf

Related Stories

Thermal imaging shatters arousal gender gap myth

Oct 02, 2006

A new McGill University study that used thermal imaging technology for the first time ever to measure sexual arousal rates has turned the conventional wisdom that women become aroused more slowly than men on its head.

Recommended for you

People on higher incomes are happier with new knees

10 hours ago

Knee replacement surgery is a very common procedure. However, it does not always resolve function or pain in all the recipients of new knees. A study by Robert Barrack, MD and his colleagues from the Washington University ...

New search engine finds rare diagnoses

10 hours ago

Doctors are trained to think "common disease" when they meet patients in their practices, and as they rarely or never meet a rare disease, it often takes many years to reach the right diagnosis. A new search tool called FindZebra ...

User comments : 0

More news stories

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Changing cancer's environment to halt its spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...

New method for producing clean hydrogen

Duke University engineers have developed a novel method for producing clean hydrogen, which could prove essential to weaning society off of fossil fuels and their environmental implications.